Broadfin Capital as of Sept. 30, 2019
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 42 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 24.1 | $131M | 440k | 296.77 | |
| Spdr Series Trust S&p Biotech Put Option (XBI) | 9.9 | $53M | 700k | 76.25 | |
| Biohaven Pharmaceutical Holding | 8.0 | $43M | 1.0M | 41.72 | |
| Amarin Corp Spons Adr New (AMRN) | 4.4 | $24M | 1.6M | 15.16 | |
| Iovance Biotherapeutics (IOVA) | 3.8 | $21M | 1.1M | 18.20 | |
| BioDelivery Sciences International | 3.3 | $18M | 4.3M | 4.21 | |
| Allergan SHS | 3.0 | $16M | 97k | 168.29 | |
| Mirati Therapeutics Call Option | 2.9 | $16M | 200k | 77.91 | |
| Eiger Biopharmaceuticals | 2.6 | $14M | 1.4M | 10.25 | |
| Intersect Ent | 2.5 | $13M | 779k | 17.01 | |
| Sientra | 2.4 | $13M | 2.0M | 6.48 | |
| Nevro (NVRO) | 2.4 | $13M | 151k | 85.97 | |
| Avadel Pharmaceuticals Sponsored Adr | 2.4 | $13M | 3.1M | 4.16 | |
| Wright Med Group N V Ord Shs | 2.4 | $13M | 619k | 20.63 | |
| Abbvie (ABBV) | 2.2 | $12M | 155k | 75.72 | |
| Recro Pharma | 2.0 | $11M | 988k | 11.08 | |
| Viewray (VRAYQ) | 1.6 | $8.7M | 3.0M | 2.90 | |
| Global Blood Therapeutics In | 1.6 | $8.6M | 177k | 48.52 | |
| Progenics Pharmaceuticals | 1.5 | $8.0M | 1.6M | 5.06 | |
| Retrophin | 1.3 | $7.1M | 610k | 11.59 | |
| Strata Skin Sciences Com New | 1.2 | $6.3M | 2.9M | 2.15 | |
| Strongbridge Biopharma Shs Usd | 1.1 | $6.2M | 2.6M | 2.39 | |
| Exicure | 1.1 | $5.8M | 2.3M | 2.53 | |
| Zogenix Com New | 1.0 | $5.5M | 138k | 40.04 | |
| Sol Gel Technologies SHS (SLGL) | 0.9 | $5.1M | 563k | 8.99 | |
| Alkermes SHS (ALKS) | 0.9 | $4.9M | 249k | 19.51 | |
| Exagen (XGN) | 0.9 | $4.8M | 311k | 15.49 | |
| ICU Medical, Incorporated (ICUI) | 0.9 | $4.8M | 30k | 159.60 | |
| Quotient SHS | 0.9 | $4.8M | 613k | 7.77 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.9 | $4.7M | 880k | 5.31 | |
| Antares Pharma | 0.8 | $4.5M | 1.3M | 3.34 | |
| Si-bone (SIBN) | 0.7 | $3.9M | 223k | 17.67 | |
| Dermira | 0.7 | $3.7M | 580k | 6.39 | |
| Heron Therapeutics (HRTX) | 0.7 | $3.7M | 198k | 18.50 | |
| Vericel (VCEL) | 0.7 | $3.6M | 237k | 15.14 | |
| Gw Pharmaceuticals Ads | 0.6 | $3.5M | 30k | 115.03 | |
| Nanostring Technologies (NSTGQ) | 0.4 | $2.4M | 111k | 21.59 | |
| Adma Biologics (ADMA) | 0.4 | $2.3M | 506k | 4.45 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $1.7M | 1.6M | 1.08 | |
| La Jolla Pharmaceutical Com Par $.0001 2 | 0.3 | $1.6M | 182k | 8.80 | |
| AMAG Pharmaceuticals | 0.2 | $1.2M | 100k | 11.55 | |
| Palatin Technologies Com Par $ .01 | 0.2 | $952k | 1.0M | 0.91 |
